T-cell-rich large-B-cell lymphomas contain non-activated CD8+ cytolytic T cells, show increased tumor cell apoptosis, and have lower Bcl-2 expression than diffuse large-B-cell lymphomas

American Journal of Pathology

Volumn 153, Issue 6, 1998, Pages 1707-1715

  Felgar, Raymond E ^a,b,c   Steward, Katherine R ^a   Cousar, John B ^a   Macon, William R ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; FAS ANTIGEN; GRANZYME B; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53; T LYMPHOCYTE RECEPTOR;

ADULT; AGED; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

EID: 0031770922     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65685-4     Document Type: Article

References (45)

1. Ramsay AD, Smith WJ, Isaacson PG: T-cell-rich B-cell lymphoma. Am J Surg Pathol 1988, 12:433-443
2. Macon WR, Williams ME, Greer JP, Stein RS, Collins RD, Cousar JB: T-cell-rich B-cell lymphomas: a clinicopathologic study of 19 cases. Am J Surg Pathol 1992, 16:351-363
3. Krishnan J, Wallberg K, Frizzera G: T-cell-rich large B-cell lymphoma: a study of 30 cases supporting its histologic heterogeneity and lack of clinical distinctiveness. Am J Surg Pathol 1994, 18:455-465
4. Baddoura FK, Chan WC, Masih AS, Mitchell D, Sun NCJ, Weisenburger DD: T-cell-rich B-cell lymphoma: a clinicopathologic study of eight cases. Am J Clin Pathol 1995, 103:65-75
5. Chittal SM, Brousset P, Voigt J-J, Delsol G: Large B-cell lymphoma rich in T-cells and simulating Hodgkin's disease. Histopathology 1991, 19:211-220
6. Delabie J, Vandenberghe E, Kennes C, Verhoef G, Foschini MP, Stul M, Cassiman JJ, De Wolf-Peeters C: Histiocyte-rich B-cell lymphoma: a distinct clinicopathologic entity possibly related to lymphocyte pre-dominant Hodgkin's disease, paragranuloma subtype. Am J Surg Pathol 1992, 16:37-48
7. Farhi DC: T-cell-rich B-cell lymphoma: reflections on changes in hematopathology. Am J Clin Pathol 1995, 103:4-5
8. Greer JP, Macon WR, Lamar RE, Wolff SN, Stein RS, Flexner JM, Collins RD, Cousar JB: T-cell-rich B-cell lymphomas: diagnosis and response to therapy of 44 patients. J Clin Oncol 1995, 13:1742-1750
9. Rodriguez J, Pugh WC, Cabanillas F: T-cell-rich B-cell lymphoma. Blood 1993, 82:1586-1589
10. Skinnider BF, Connors JM, Gascoyne RD: Bone marrow involvement in T-cell-rich B-cell lymphoma. Am J Clin Pathol 1997, 108:570-578
11. Kawada H, Watanabe S, Yoshida M, Fukuda R, Kobayashi N, Masumoto A, Ogawa Y, Ohbayashi Y, Yonekura S, Ichikawa Y: Flow cytometric analysis of T-cell-rich B-cell lymphoma. Acta Haematol 1994, 92:164-166
12. Felgar RE, Macon WR, Kinney MC, Roberts S, Pasha T, Salhany KE: TIA-1 expression in lymphoid neoplasms: identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation. Am J Pathol 1997, 150:1893-1900
13. Macon WR, Salhany KE: T-cell subset analysis of peripheral T-cell lymphomas by paraffin immunoperoxidase and correlation of CD4/ CD8 results to flow cytometry. Am J Clin Pathol 1998, 109:610-617
14. Oudejans JJ, Kummer JA, Jiwa M, van der Valk P, Ossenkoppele GJ, Kluin PM, Kluin-Nelemans JC, Meijer CLM: Granzyme B expression in Reed-Sternberg cells of Hodgkin's disease. Am J Pathol 1996, 148: 233-240
15. Macon WR, Cousar JB, Waldron JA, Hsu S-M: Interleukin-4 may contribute to the abundant T-cell reaction and paucity of neoplastic B cells in T-cell-rich B-cell lymphomas. Am J Pathol 1992, 141:1031-1036
16. Shipley WR, Hammer RD, Lennington WJ, Macon WR: Paraffin immunohistochemical detection of CD56, a useful marker for neural cell adhesion molecule (NCAM), in normal and neoplastic fixed tissues. Appl Immunohistochem 1997, 5:87-93
17. + T lymphocytes. J Immunol 1990, 144:574-582
18. Anderson P: TIA-1: Structural and functional studies on a new class of cytolytic effector molecule. Curr Top Microbiol Immunol 1995, 198: 131-143
19. Tian Q, Streuli M, Saito H, Schlossman SF, Anderson P: A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells. Cell 1991, 67:629-639
20. Medley QG, Kedersha N, O'Brien S, Tian Q, Schlossman SF, Streuli M, Anderson P: Characterization of GMP-17, a granule membrane protein that moves to the plasma membrane of natural killer cells following target cell recognition. Proc Natl Acad Sci USA 1996, 93: 685-689
21. Boulland M-L, Kanavaros P, Wechsler J, Casiraghi O, Gaulard P: Cytotoxic protein expression in natural killer cell lymphomas in αβ and γδ peripheral T-cell lymphomas. J Pathol 1997, 183:432-439
22. Berke G: The CTL's kiss of death. Cell 1995, 81:9-12
23. Liu C-C, Young LHY, Young JD-E: Lymphocyte mediated cytolysis and disease. N Engl J Med 1996, 335:1651-1659
24. Young JD-E, Liu CC: Multiple mechanisms of lymphocyte-mediated killing. Immunol Today 1988, 9:140-144
25. Wijsman JH, Jonker RR, Keijzer R, van de Velde CJ, Cornelisse CJ, van Dierendonck JH: A new method to detect apoptosis in paraffin sections: in situ end labeling of fragmented DNA. J Histochem Cytochem 1993, 41:7-12
26. Thiry M: Highly sensitive immunodetection of DNA on sections with exogenous terminal deoxynucleotidyl transferase and non-isotopic nucleotide analogues. J Histochem Cytochem 1992, 40:411-419
27. Grasl-Kraupp B, Ruttkay-Nedecky B, Koudelka H, Bukowska K, Bursch W, Schulte-Hermann R: In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology 1995, 21:1465-1468
28. Gold R, Schmied M, Giegrich G, Breitschopf H, Hartung HP, Toyka KV, Lassmann H: Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest 1994, 71:219-225
29. Diaz J, Tubbs R, Stoler M, Grogan T: Cytolytic (TIA-1+) tumor infiltrating lymphocytes in B cell non-Hodgkin's lymphomas. Leuk Lymphoma 1993, 9:91-94
30. Wang Q, Stanley J, Kudoh S, Myles J, Kolenko V, Yi T, Tubbs R, Bukowski R, Finke J: T cells infiltrating non-Hodgkin's B cell lymphomas show altered tyrosine phosphorylation pattern even though T cell receptor/CD3-associated kinases are present. J Immunol 1995, 155: 1382-1392
31. Yonehara S, Ishii A, Yonehara M: A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 1989, 169:1747-1756
32. Trauth BC, Klas C, Peters AMJ, Matzku S, Moller P, Flak E, Debatin KM, Krammer PH: Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989, 245:301-305
33. Hanabuchi S, Koyanagi M, Kawasaki A, Shinohara N, Matsuzawa A, Nishimura Y, Kobayashi Y, Yonehara S, Yagita H, Okumura K: Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity. Proc Natl Acad Sci USA 1994, 91:4930-4934
34. Oren M: Relationship of p53 to the control of apoptotic cell death. Semin Cancer Biol 1994, 5:221-227
35. Nguyen PL, Harris NL, Ritz J, Robertson MJ: Expression of CD95 antigen and bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease. Am J Pathol 1996, 148:847-853
36. Hahn S, Gehri R, Erb P: Mechanism and biological significance of CD4-mediated cytotoxicity. Immunol Rev 1995, 146:57-79
37. Takayama H, Kojima H, Shinohara N: Cytotoxic T lymphocytes: The newly identified fas (CD95)-mediated killing mechanism and a novel aspect of their biological functions. Adv Immunol 1995, 60:289-321
38. Vogelstein B, Kinzler KW: p53 function and dysfunction. Cell 1992, 70:523-526
39. Lane DP: p53 and human cancers. Br Med Bull 1994, 50:582-599
40. Cattoretti G, Becker MH, Key G, Duchrow M, Schluter C, Galle J, Gerdes J: Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB-1 and MIB-3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992, 168: 357-363
41. Reed JC: Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. Curr Opin Oncol 1995, 7:541-546
42. Yang E, Korsmeyer SJ: Molecular thanatopsis: a discourse on the BCL-2 family and cell death. Blood 1996, 88:386-401
43. Fukuhara S, Rowley JD, Variakojis D, Golomb HM: Chromosome abnormalities in poorly differentiated lymphocytic lymphoma. Cancer Res 1979, 39:3119-3128
44. Yunis JJ, Frizzera G, Oken MM, McKenna J, Theologides A, Arnesen M: Multiple recurrent genomic defects in follicular lymphoma: a possible model for cancer. N Engl J Med 1987, 316:79-84
45. Cleary ML, Smith SD, Sklar J: Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell 1986, 47:19-28